Financial News
Curevac N.V. (NQ: CVAC )
3.130
+0.360
(+13.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Press Releases about Curevac N.V.
From CureVac
Via AccessWire
CureVac Announces Voting Results of General Meeting
June 22, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
From CureVac
Via AccessWire
Curevac Announces Financial Results For The First Quarter Of 2022 And Provides Business Update
May 25, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update
April 28, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
From CureVac
Via AccessWire
CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
March 30, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
From CureVac
Via AccessWire
From CureVac
Via AccessWire
CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Technology
October 12, 2021
From CureVac
Via AccessWire
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots
September 17, 2021
Exposures
COVID-19
CureVac Streamlines European Network for mRNA Product Manufacturing
September 14, 2021
From CureVac
Via AccessWire
From CureVac
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.